Aurobindo asks US judge to reconsider judgment against states' antitrust claims over PioMet
MLex Summary: Aurobindo Pharma asked a US federal judge to reconsider a summary judgment against states’ antitrust claims over the drug PioMet. Aurobindo said reconsideration is appropriate because the court’s antitrust...To view the full article, register now.
Already a subscriber? Click here to view full article